Grupo IMO

About Grupo IMO

Grupo IMO, operating under the name IMO Grupo Miranza, is a specialized ophthalmological institute with a history of over 35 years. The organization began its journey in the mid-1980s with a single clinic in Barcelona, focusing on private medicine. A significant milestone was achieved in 2009 with the inauguration of a new, expansive 24,000-square-meter facility in Barcelona, which includes 70 consulting rooms and 8 operating theaters. This center handles approximately 65,000 visits and 8,000 surgeries annually. In 2019, the Institute of Ocular Microsurgery (IMO) joined Miranza, a prominent group of ocular wellness centers across Spain. This merger facilitated expansion, leading to the opening of new locations in Madrid and Manresa in 2020, and an international leap in 2022 by integrating a clinic in Andorra.

The company operates in the specialized healthcare market, positioning itself as a reference for complex ophthalmological surgical procedures. Its business model is centered on providing comprehensive eye care services, from diagnosis and treatment of common and complex eye diseases to elective procedures like refractive surgery and aesthetic eye therapies. The firm serves a broad client base, including local and international patients, and often takes on complex cases referred by other clinics globally. Revenue is generated through the provision of these medical and surgical services.

The core of Grupo IMO's service is its team of highly specialized ophthalmologists, each focusing on a specific part of the eye, which allows for a deep understanding of particular pathologies. This multidisciplinary team approach makes the clinic a reference point for combined and high-complexity surgeries. Key areas of expertise include cataracts, glaucoma, retina, cornea, refractive surgery, and pediatric ophthalmology. A distinguishing feature is the Barcelona clinic's in-house molecular biology laboratory, a unique asset in Spain that is dedicated to genetic diagnostics and research into new therapies for eye diseases that currently have no cure. The clinic is also the first ophthalmology center in Barcelona to receive the Joint Commission International (JCI) quality seal, underscoring its commitment to patient care and safety standards.